Related Experiment Video
Updated: Dec 17, 2025

Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells
Published on: September 30, 2018
CRABP2 and FABP5 expression levels in diseased and normal pancreas
Christine S Hughes1, Jo-Anne ChinAleong2, Hemant M Kocher3
1Centre for Tumour Biology, Barts Cancer Institute - a CR-UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK.
Abstract:
Recently, stromal targeting, by agents such as All trans retinoic acid (ATRA), has been regarded as a promising avenue for the treatment of pancreatic ductal adenocarcinoma (PDAC). The intra-cellular transportation of ATRA to the nuclear receptors is performed by either: fatty acid binding protein 5 (FABP5) or cellular retinoic acid binding protein 2 (CRABP2), dictating the transcription of downstream genes and, thus, eventual cell phenotype. Here, we explored the levels of each protein, in pancreatic tissues of patients presenting with a range of pancreatic diseases (pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), cholangiocarcinoma (CC)). We demonstrate that there is a significantly lower CRABP2 and FABP5 expression in activated fibroblasts or pancreatic stellate cells (PSC) in PDAC, as well as other diseased pancreas as in CC and CP, versus quiescent fibroblasts. The quiescent fibroblasts consistently show a pattern of high FABP5:CRABP2 ratio, whereas PSC in all non-PDAC tissues showed a low FABP5:CRABP2 ratio. PSC in PDAC patients had a range of FABP5:CRABP2 ratios (high, even and low). There was a lower CRABP2 expression in cancerous epithelial cells (PDAC) versus normal epithelial cells. This is also present in other disease states (CP, CC). Contrasting to the patterns seen for fibroblasts, the FABP5 expression in PDAC epithelial cells matched that of the normal epithelial cells. However, the normal epithelial cells had a high FABP5:CRABP2 ratio, compared to the PDAC epithelial cells. These ratios may have correlation with tumor progression, and overall survival. These findings could be confirmed in in vitro cell lysates. CRABP2 and FABP5 levels and ratios could serve as valuable biomarkers.
Insights
Cellular retinoic acid binding protein 2 (CRABP2) and fatty acid binding protein 5 (FABP5) levels differ in pancreatic tissues. These protein ratios may serve as biomarkers for pancreatic ductal adenocarcinoma (PDAC) progression.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Stromal targeting with All trans retinoic acid (ATRA) shows promise for pancreatic ductal adenocarcinoma (PDAC) treatment.
- Intracellular ATRA transport to nuclear receptors is mediated by fatty acid binding protein 5 (FABP5) or cellular retinoic acid binding protein 2 (CRABP2), influencing gene transcription and cell phenotype.
Purpose of the Study:
- To investigate the expression levels and ratios of FABP5 and CRABP2 in pancreatic tissues from patients with PDAC, chronic pancreatitis (CP), and cholangiocarcinoma (CC).
- To explore the potential of FABP5 and CRABP2 as biomarkers for pancreatic diseases and tumor progression.
Main Methods:
- Analysis of FABP5 and CRABP2 expression in pancreatic tissues (PDAC, CP, CC) and normal tissues.
- Comparison of protein expression and ratios between activated/quiescent fibroblasts, pancreatic stellate cells (PSCs), and epithelial cells.
- Correlation analysis of protein levels and ratios with disease state and potential clinical outcomes.
Main Results:
- Lower CRABP2 and FABP5 expression observed in activated PSCs from PDAC, CC, and CP tissues compared to quiescent fibroblasts.
- Quiescent fibroblasts exhibited a high FABP5:CRABP2 ratio; PSCs in non-PDAC diseases showed a low ratio.
- PDAC PSCs displayed variable FABP5:CRABP2 ratios. CRABP2 expression was lower in cancerous epithelial cells (PDAC) versus normal cells, a trend also seen in CP and CC.
- PDAC epithelial cells showed similar FABP5 expression to normal cells, but normal cells had a higher FABP5:CRABP2 ratio.
Conclusions:
- FABP5 and CRABP2 expression patterns and their ratios differ significantly between normal and diseased pancreatic tissues, including PDAC.
- These distinct protein expression profiles and ratios in fibroblasts and epithelial cells suggest their potential as valuable biomarkers for pancreatic diseases and tumor progression.
- Further in vitro studies are warranted to confirm these findings and validate FABP5 and CRABP2 as reliable biomarkers.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cell Specific Gene Expression

